Trade Summary

4 days ago, Scholl Hendrik Peter, serving as Chief Medical Officer at BELITE BIO, INC (BLTE), sold 10,000 shares at $145.24 per share, for a total transaction value of $1,452,435.21. Following this transaction, Scholl Hendrik Peter now holds 15,000 shares of BLTE.

This sale represents a 40.00% decrease in Scholl Hendrik Peter's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 18, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 22, 2026 at 6:05 AM ET, 4 days after the trade was made.